Ovid Therapeutics is a company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Hosted by Amit Rakhit, MD, MBA, this is our podcast. This is Bold Medicine.
"What's it going to take? it all comes down to WHO can we get involved. We have to keep reminding ourselves it's not about problems, it's about soluti...
Amanda Moore joins us to talk about her new role as CEO of the Angelman Syndrome Foundation and her leadership within the rare disease community. Aman...
Karen Utley, President and co-Founder of the International Foundation for CDKL5 Research speaks with Amit about what it's like to be a leader in the r...
As we enter the season of high school prom and joining community and friends to celebrate, Autism advocate and nonprofit founder Stephanie Mishler joi...
We're back, and there's no better time to kick off the 2019 season of BoldMedicine. February 28th is Rare Disease Day! Throughout the month of Februar...
Terry Jo Vetters Bichell has been the Director/Scientific Officer of the Angelman Biomarkers and Outcome Measures Alliance (A-BOM) since its inception...
Becky Burdine impacts the rare disease community, the Angelman syndrome community and the scientific community in every way possible. Her approach is ...
Amit speaks with Kendall James-Davis, Senior Manager of Strategic Alliances at Global Genes, about the impact of patient involvement in discovery. Ken...
Amit is joined by Sam and Alexis Maydew, parents of a child with Angelman Syndrome. The Maydew's talk about their journey as parents, advocates and le...